
R&D tax relief schemes in the UK are designed to help businesses offset costs associated with innovation. There are three options: SME R&D Tax Relief, RDEC (Research and Development Expenditure Credit) for larger companies, and ERIS (Enhanced R&D Intensive Scheme) for R&D-heavy SMEs. Each scheme has distinct eligibility rules, financial benefits, and claim processes.
| Scheme | Eligibility | Relief Offered | Key Considerations |
|---|---|---|---|
| SME R&D Tax Relief | <500 employees, turnover ≤ £100m | Enhanced deduction or cash credit | Best for smaller firms; state aid can limit access |
| RDEC | ≥500 employees, turnover > £100m | Taxable credit | Simpler but less generous than SME relief |
| ERIS | SMEs with ≥30% R&D spend | Higher relief for R&D-intensive firms | Requires consistent R&D investment |
Understanding which scheme fits your business depends on size, R&D intensity, and funding sources. Proper documentation and compliance with HMRC rules are critical to avoid issues. Seek expert advice if needed to maximise benefits and simplify the process.
Eligibility for R&D tax relief depends on your company's size, structure, and specific circumstances. These factors determine whether your claim falls under the SME scheme, RDEC, or ERIS.
Here’s a closer look at the qualifications for each scheme.
To qualify for the SME scheme, your company must meet the European Commission's criteria for small and medium-sized enterprises. This means your business should have fewer than 500 employees and either an annual turnover of £100 million or less or a balance sheet total of £86 million or less.
However, size alone doesn’t guarantee eligibility. The independence requirement is also critical. If another company owns 25% or more of your business, or if your company owns 25% or more of another business, this could affect your SME status.
Additionally, your R&D activities must be carried out in-house by your employees or through approved subcontracting arrangements.
Companies that exceed the SME size thresholds must claim under the RDEC scheme. This applies to businesses with 500 or more employees, or those with an annual turnover exceeding £100 million and a balance sheet total over £86 million.
Interestingly, some SMEs must also claim under RDEC. This typically happens when their R&D projects receive state aid, such as government grants or EU funding. State aid rules prevent these businesses from accessing the more generous SME relief rates to avoid double funding.
ERIS is tailored for R&D-intensive SMEs that might otherwise lose access to enhanced relief because of investment or state aid restrictions. To qualify, your company must meet SME criteria but have R&D expenditure equalling at least 30% of total spending over a three-year period.
This scheme is particularly beneficial for SMEs that receive significant investment or grants but maintain a high level of R&D activity compared to their overall operations.
The table below summarises the key qualifications for each scheme:
| Qualification Factor | SME Scheme | RDEC | ERIS |
|---|---|---|---|
| Employees | <500 employees | ≥500 employees | <500 employees |
| Turnover threshold | ≤£100m | >£100m | ≤£100m |
| Balance sheet limit | ≤£86m | >£86m | ≤£86m |
| Independence requirement | Must be independent | No requirement | Limited by investment/state aid |
| R&D intensity requirement | None | None | ≥30% of total expenditure over 3 years |
| State aid restrictions | Cannot receive state aid | No restrictions | Designed for companies with state aid |
There are specific situations where SMEs are required to claim under RDEC rather than the SME scheme. For example, R&D activities conducted overseas often fall under RDEC rules, even if the SME qualifies otherwise. This includes work done by overseas subsidiaries or subcontracted to foreign entities, though exceptions may apply for activities within the EEA.
Another factor is the capping rules. If your R&D tax credits exceed your company’s total PAYE and National Insurance liability for the year, the excess may need to be claimed under RDEC instead.
Getting the classification right is essential to avoid delays with HMRC and ensure your claim is processed accurately.
When it comes to financial returns, the differences between R&D tax relief schemes are substantial and play a key role in shaping both investment decisions and claim values. Here's a closer look at how these schemes impact businesses.
The SME scheme allows companies to claim an enhanced deduction on their qualifying R&D expenditure. For profitable SMEs, this deduction can significantly reduce taxable profits, effectively lowering their tax liability. For loss-making businesses or those without enough profits to absorb the deduction, there’s an alternative - a cash credit based on their R&D spend. This flexibility helps SMEs reduce the overall cost of their R&D activities, making innovation more accessible.
The R&D Expenditure Credit (RDEC) scheme provides a taxable credit for eligible R&D spending. While this credit is treated as taxable income, it can either offset corporation tax liabilities or, under specific conditions, be paid out as a cash sum. This structure offers businesses a predictable way to manage tax offsets and plan their cash flow effectively.
The Enhanced R&D Intensive Scheme (ERIS) is tailored for SMEs that dedicate a significant portion of their resources to R&D. ERIS offers higher relief rates, benefiting profitable companies with greater tax savings or providing cash credits for businesses operating at a loss. However, to qualify, companies need to demonstrate consistent R&D investment over a specified period, ensuring the scheme supports those truly focused on innovation.
The UK’s R&D tax relief framework has undergone several reforms in recent years. Relief and credit rates have been adjusted to bolster the competitiveness of the innovation sector. Some changes were introduced temporarily and later revised based on industry feedback. To stay compliant and maximise claims, businesses should consult the latest HMRC guidelines, as these updates influence both claim calculations and cash flow.
| Scheme | Relief Benefit | Profit Saving Option | Cash Credit Option | Key Considerations |
|---|---|---|---|---|
| SME | Enhanced deduction on qualifying expenditure | Reduces taxable profits significantly | Available for loss-making companies | Helps lower R&D costs for smaller businesses |
| RDEC | Taxable credit on qualifying expenditure | Offsets corporation tax liabilities | Can be received as a cash payment under certain conditions | Offers a predictable and straightforward process |
| ERIS | Higher relief for R&D-intensive SMEs | Provides enhanced tax savings | Available as a cash credit for loss-making companies | Requires proof of sustained R&D activity |
Each scheme has its own calculation process. For SME relief, claims are made through the company’s corporation tax return by adjusting taxable profits with the enhanced deduction. RDEC claims are calculated separately and appear as a credit within the tax computation. ERIS follows a similar process to SME relief but includes additional checks to confirm the company’s ongoing R&D intensity.
The differences in how these schemes operate have a direct effect on cash flow and planning. For SMEs, cash credits can provide quick funding, offering a lifeline for businesses needing immediate capital. While RDEC delivers a lower percentage benefit, it’s simpler to administer and provides steady, predictable returns. These cash flow advantages enable businesses to adapt their tax relief strategies, ensuring they can sustain their innovation efforts over the long term.
Submitting claims for R&D tax relief demands a careful approach to both process and documentation. Below, we break down the steps for SME, RDEC, and ERIS claims, along with additional requirements and tips for success.
For SMEs, claims are submitted through the corporation tax return using the CT600 form. The R&D section of the tax return must be completed, clearly outlining qualifying expenditure and calculating the enhanced deduction or cash credit. It's important to note that claims must be filed within two years of the end of the accounting period during which the R&D costs were incurred.
Maintaining detailed records is essential. These should clearly link your expenditure to qualifying R&D activities, ensuring you have the documentation ready if required for further review.
The process for RDEC claims is similar but involves additional forms. Alongside the corporation tax return, companies must complete Form CT600A, which provides a detailed breakdown of R&D expenditure and the corresponding credit calculation. As with SME claims, accurate records and consistent categorisation of costs are critical. This ensures that all relevant information is available when moving on to the specific documentation requirements of the scheme.
ERIS claims come with extra steps to verify a company’s R&D intensity over a three-year period. This requires clear and consistent categorisation of R&D and non-R&D costs. The intensity calculation must remain stable across accounting periods, and any major changes in business structure or spending need to be promptly reported to HMRC, as they may impact eligibility.
Changes introduced for 2023-24 have brought stricter requirements, including the need for more detailed project descriptions and expenditure breakdowns. These updates reflect HMRC’s increased focus on compliance, often leading to longer preparation times for claims.
Thorough documentation is the cornerstone of a successful R&D claim. Companies should maintain up-to-date records that directly tie expenditures to qualifying R&D activities. Examples of useful documentation include project plans, technical reports, meeting minutes, and financial records that substantiate the R&D nature of the work.
Staff time records are particularly important, as labour costs often represent a significant portion of R&D expenditure. Detailed timesheets showing how employees allocate their time to qualifying R&D activities, rather than routine tasks, should be maintained throughout the project.
Navigating the complexities of R&D tax relief claims can be challenging, especially given the recent administrative updates. Engaging professional support can help ensure compliance with HMRC standards and maximise the relief available.
Specialists like Zest R&D Tax Advisors offer expertise in preparing claims, categorising expenses, and handling the extensive documentation requirements. Their support can make a significant difference by ensuring businesses meet all regulatory standards while focusing on their core operations. By managing compliance and adapting to regulatory changes, professional advisors allow companies to focus on what they do best, leaving the intricacies of the claims process in capable hands.
Effective submission and documentation practices are essential for a successful claim, building a strong foundation for the preparation strategies outlined earlier.
Understanding the strengths and limitations of each R&D tax relief scheme is key to crafting an effective claim strategy. By evaluating their financial benefits, eligibility criteria, and administrative demands, businesses can align their approach with their needs and goals.
SME R&D Tax Relief offers generous financial support and a lot of flexibility in what qualifies as R&D. This makes it highly appealing for smaller businesses engaged in innovative work. However, companies need to be mindful that growing beyond the SME criteria means switching to RDEC, which comes with reduced benefits.
RDEC, on the other hand, is a dependable option for larger organisations. It supports a variety of corporate structures and has fewer restrictions on qualifying expenditures, making it easier to plan financially. That said, the financial benefits are less substantial compared to SME R&D Relief, and the documentation requirements are more demanding.
Enhanced R&D Intensive Scheme (ERIS) is designed to reward R&D-intensive SMEs with greater benefits. However, it comes with strings attached - consistent R&D spending is required, and the documentation demands are rigorous, potentially driving up advisory costs. Any significant drop in R&D activity could jeopardise eligibility.
Here’s a quick comparison of the key features:
| Aspect | SME R&D Relief | RDEC | ERIS |
|---|---|---|---|
| Financial Benefit | Higher incentives | Stable but lower benefits | Enhanced for R&D-focused firms |
| Eligibility Flexibility | High for eligible SMEs | Broad company eligibility | Limited to firms with significant R&D |
| Documentation Requirements | Standard level | More extensive | Most demanding due to compliance rules |
| Long-term Stability | May phase out as firms grow | Stable for larger companies | Relies on consistent R&D spending |
| Administrative Burden | Lower | Higher | Highest due to rigorous checks |
Choosing the right scheme will depend on the specific circumstances of your business. SME R&D Tax Relief is highly beneficial for smaller companies, but growing businesses will eventually need to consider RDEC. For those heavily invested in research and development, ERIS could be a valuable option, despite its complexity.
It's also worth noting that recent regulatory changes have increased compliance requirements across all schemes. This can be particularly challenging for smaller businesses with limited resources to handle the added administrative workload.
The success of claiming R&D tax relief depends heavily on understanding your company's size, structure, and the extent of its R&D activities. For smaller businesses, SME R&D Tax Relief offers increased deductions and cash credits, making it an attractive option. However, as businesses grow and exceed SME thresholds, they shift to the RDEC scheme, which provides broader eligibility and a more stable framework.
For SMEs with high levels of R&D spending, the ERIS scheme offers additional benefits, though it often comes with increased administrative demands. Choosing the right scheme requires careful consideration of factors like your company’s growth, R&D expenditure trends, and your ability to handle compliance requirements. Larger businesses, in particular, may find RDEC appealing due to its structured and reliable approach.
With HMRC's evolving regulations, it’s crucial to ensure claims are accurate and compliant. Seeking expert advice from Zest R&D Tax Advisors can help streamline the process, maximise returns, and reduce the administrative load.
The difference between these schemes comes down to eligibility criteria and the level of benefit they provide. SME R&D Tax Relief is designed for small and medium-sized enterprises with fewer than 500 employees and either a turnover of less than €100 million or gross assets under €86 million. This scheme allows an enhanced deduction of 86% on qualifying R&D costs, which can result in substantial tax savings or a payable tax credit for businesses operating at a loss.
The RDEC scheme is intended for larger companies that exceed these thresholds. However, SMEs can also access it in specific situations, such as when they are subcontracted to carry out R&D for a larger company or when grant funding is involved. This scheme offers a taxable credit, providing a net benefit of 16.2% of qualifying expenditure after tax.
While the SME scheme tends to offer greater benefits, the choice between the two depends on factors like your company’s size, activities, and funding arrangements. Knowing these differences can help you make the most of your R&D tax relief.
To qualify for the Enhanced R&D Intensive Scheme (ERIS), small and medium-sized enterprises (SMEs) must meet certain conditions. Starting from accounting periods beginning on or after 1 April 2024, the company must be loss-making and demonstrate that qualifying R&D expenditure makes up at least 30% of its total spending. SMEs are defined as businesses with fewer than 500 employees and either an annual turnover not exceeding €100 million or gross assets capped at €86 million.
The ERIS scheme provides considerable advantages, including an enhanced R&D tax relief rate tailored for loss-making SMEs. Eligible companies can claim a total deduction of 186% on qualifying R&D expenses and may receive a payable tax credit of up to 14.5% of their surrenderable loss. This initiative offers a valuable way for SMEs to cut expenses and support their innovation projects.
One of the biggest hurdles businesses face when claiming R&D tax relief is not fully understanding the distinction between the SME scheme and the Research and Development Expenditure Credit (RDEC). Filing under the wrong scheme can lead to lost benefits or even compliance issues with HMRC. Another common challenge is pinpointing which projects and costs qualify - this could include staff wages, subcontractor fees, or software-related expenses.
To ensure compliance, your projects must align with HMRC’s definition of R&D, which centres on achieving scientific or technological progress. Keeping detailed records of all qualifying expenses is crucial, along with having a strong grasp of the specific rules tied to the scheme you’re using. By maintaining accurate documentation and understanding the eligibility criteria, you can minimise mistakes and make the most of your claim.

R&D tax relief for software & SaaS companies: what qualifies, what HMRC treats as routine, and which costs (including cloud) you can claim.

Since 18 May 2026 your R&D tax adviser must be registered with HMRC. Here’s what the rule means and what to check before you let anyone file your claim.

A guide to R&D tax relief for engineering firms: which projects and costs qualify, how the merged scheme and ERIS work, and how to make a claim that survives HMRC.